FindTrial
Sign In

Protective antibiotic titres for measles, mumps and rubella in children and adolescents with chronic kidney disease

Seroprotection for measles, mumps and rubella in children and adolescents with chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019873
Enrollment
60
Registered
2019-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Control Intervention1: Antibody titres for measles, mumps and rubella.: seroprotection for measles, mumps and rubella in children and adolescents with chronic kidney disease.

Sponsors

Maulana Azad medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children and adolescents aged between 2-19 years with chronic kidney disease who have received atleast one dose of measles containing vaccine.

Exclusion criteria

Exclusion criteria: children and adolescents having received immunosuppressive drugs, unimmunized children with chronic kidney disease.

Design outcomes

Primary

MeasureTime frame
proportion of children and adolescents with chronic kidney disease seroprotected for measles, mumps and rubella as assessed by antimeasles, antimumps, antirubella titres.Timepoint: 1 year—

Secondary

MeasureTime frame
Association of antibody titres with age, duration, cause and stages of chronic kidney disease.Timepoint: 1 year—

Countries

India

Contacts

Public ContactMukta Mantan

Maulana Azad Medical College

muktamantan@hotmail.com9968604315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026